COMMUNIQUÉS West-GlobeNewswire

Actions de développement de la zone Moyen-Orient : congrès et formation chirurgiens
18/06/2024
Communiqué de presse Ecully, le 18 juin 2024 – 18h Présentation du système KAPHORN devant 200 chirurgiens au congrès de la SOTCOT à Hammamet Le groupe Spineway spécialiste des implants innovants pour le traitement des [...]
XBiotech Results from Randomized Double-Blinded Phase 1/2 Study Suggest Potential Breakthrough Treatment for Advanced Pancreatic Cancer
18/06/2024
Findings Show Trends for Reduced Toxicities and Better Outcomes for Subjects Receiving ONIVYDE/5-FU Combination and Targeted anti-IL-1alpha Therapy AUSTIN, Texas, June 18, 2024 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ: XBIT [...]
Milestone Scientific Receives Regulatory Approval to Market CompuFlo® Epidural System in Brazil
18/06/2024
Brazil is the 9th largest economy in the world with more than 21 million people suffering from chronic back pain An estimated 4-5 million epidural anesthesia procedures are performed annually in Brazil; potential to [...]
GlycoProteMim Featured in Stonegate Healthcare’s Latest Anti-Aging Research Report
18/06/2024
VANCOUVER, British Columbia, June 18, 2024 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) is pleased to announce that its innovative anti-aging ingredient, GlycoProteMim™, has been [...]
Acentra Health Names Heather Adamson as Senior Vice President of Marketing
18/06/2024
MCLEAN, Va., June 18, 2024 (GLOBE NEWSWIRE) -- Acentra Health, a technology solutions and clinical services company dedicated to helping government healthcare agencies accelerate better health outcomes, today announced [...]
Santhera’s Shareholders Approve all Board Proposals at Today’s Annual General Meeting
18/06/2024
Pratteln, Switzerland, June 18, 2024 – Santhera Pharmaceuticals (SIX: SANN) announces that its shareholders approved all motions by the Board of Directors at the Annual General Meeting (AGM) held today in Pratteln, [...]
Merit Medical Systems to Announce Second Quarter 2024 Results on August 1, 2024
18/06/2024
SOUTH JORDAN, Utah, June 18, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial [...]
Kriya Appoints Katherine Eade as Chief Legal Officer
18/06/2024
– Experienced biopharma executive to guide Kriya’s overarching legal strategy across corporate affairs, gene therapy R&D, and technology & manufacturing platforms – PALO ALTO, Calif., and RESEARCH TRIANGLE PARK [...]
Positron Corporation Announces Attrius® PET System Sale
18/06/2024
Niagara Falls, NY, June 18, 2024 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company offering PET and PET-CT (Positron Emission [...]
Shuttle Pharma Appoints Timothy Lorber as Chief Financial Officer
18/06/2024
Current CFO, Michael Vander Hoek, transitions to full-time Vice President, Regulatory GAITHERSBURG, Md., June 18, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a [...]
Day One Expands Pipeline with Potential First-in-Class Clinical-Stage Antibody Drug Conjugate (ADC) Targeting PTK7 in Solid Tumors for Adult and Pediatric Cancers
18/06/2024
Day One receives exclusive license for development and commercialization of MTX-13 (DAY301), which received IND clearance by the FDA in April 2024 Targets PTK7, highly expressed in broad range of adult and pediatric [...]
Elicio Therapeutics Reports Inducement Grants
18/06/2024
BOSTON, June 18, 2024 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio Therapeutics” or “Elicio”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the [...]
Intelligent Bio Solutions Begins Subject Dosing and Sampling for FDA 510(k) Pharmacokinetic (PK) Study for its Intelligent Fingerprinting Drug Screening Technology
18/06/2024
Pharmacokinetic study is key step on path to expansion into US market NEW YORK, June 18, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company [...]
Prenetics Announces First Quarter 2024 Financial Results
18/06/2024
First Quarter Revenue Increased 30.2% and Gross Profit Increased 159.8% from Prior Year Quarter Confirms Strategic Pivot Targeting the U.S. Consumer Healthcare Market Reaffirms 2024 Revenue Range of US$33 million to US$ [...]
FOXO Technologies Inc. Secures Up to $2.8 Million in Senior Notes to Fund Previously Announced Acquisition of Myrtle Recovery Centers, Inc. and Provide Additional Working Capital
18/06/2024
MINNEAPOLIS, MN, June 18, 2024 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the “Company” or “FOXO”), today announced that it has secured up to $2.8 million in Senior Notes from an institutional [...]
Cerevance Presents at The Federation of European Neuroscience Societies (FENS) Forum 2024
18/06/2024
BOSTON, June 18, 2024 (GLOBE NEWSWIRE) -- Cerevance, a company focused on developing precision novel therapeutics for central nervous system (CNS) diseases, will deliver a poster presentation at the upcoming Federation [...]
Pressure BioSciences, Inc. to Host Business and Financial Update on Thursday, June 20th at 4:30pm ET
18/06/2024
NOTE CHANGE IN DATE OF UPDATE CALL TO THURSDAY JUNE 20th CANTON, Mass., June 18, 2024 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBIO” and the “Company”) today announced that the Company will host a [...]
Upswing Health and Hinge Health Partner to Address Care for Acute MSK Injuries for Joint Clients
18/06/2024
STAMFORD, Conn., June 18, 2024 (GLOBE NEWSWIRE) -- Upswing Health , the surgeon-founded virtual orthopedic care company, today announced a partnership with Hinge Health , a company dedicated to transforming the way that [...]
Novo Nordisk announces presentation of data from key semaglutide clinical trials in diabetes, obesity and chronic kidney disease at the 84th Scientific Sessions of the American Diabetes Association
18/06/2024
FLOW kidney outcomes trial data evaluating efficacy and safety of once-weekly semaglutide 1.0 mg in people with type 2 diabetes 1 SELECT cardiovascular outcomes trial data evaluating efficacy and safety of once-weekly [...]

Pages